Odriscoll, Cath
May 2006
ICIS Chemical Business;5/29/2006, Vol. 1 Issue 21, p41
Trade Publication
The article presents news briefs on innovations of the chemical industry. Business intelligence group Visiongain reports that the world biopharmaceutical market is no longer confined to growth hormones, insulin and red blood cell-stimulating agents, but has expanded to include diseases such as arthritis, multiple sclerosis and orphan diseases. The United Nations' Food and Agriculture Organisation has asked DuPont to provide supplies of its vetinary disinfectant Virkon 5 to help prevent the spread of bird flu in 69 nations. A consortium of Dutch industrial companies, learned societies and public organisations has been joined to promote the Netherlands as a leader in the field of biomedical materials.


Related Articles

  • DuPont recommends raising HCFC-123 AEL to 50ppm.  // Contractor Magazine;Sep97, Vol. 44 Issue 9, p42 

    States that the Acceptable Exposure Limit (AEL) of hydrocholorfluorocarbon (HCFC)-123 be raised to 50 parts per million (ppm) by the DuPont Acceptable Exposure Limit Committee. What was the former rate of the AEL of HCFC-123; Reference to the Workplace Environmental Exposure Limit (WEEL);...

  • `The Miracles of Science': The new motto of DuPont's greener and more profitable future.  // Chemical Business;Feb2000, Vol. 14 Issue 2, p12 

    Focuses on DuPont, a chemical company. Overview of the operations of DuPont; Achievements of the company; Efforts to reduce greenhouse gas emissions from its operations; Safety measures implemented by the company.

  • DuPont revamps chemicals and specialties with increasing focus on life sciences. Chang, Joseph // Chemical Market Reporter;04/13/98, Vol. 253 Issue 15, p1 

    Reports on E.I. du Pont de Nemours & Co.'s plans to focus on life sciences and realign its chemical and specialties businesses into three distinct groups. Units in the life sciences group; Impact of the moves to the company's management.

  • DuPont to expand adipic acid.  // Chemical Market Reporter;03/30/98, Vol. 253 Issue 13, p3 

    Reports on the plans of E.I. du Pont de Nemours & Co.'s DuPont Nylon division to expand its adipic acid capacity in North America.

  • DuPont studies opportunities for basic chemicals investment. Hunter, David // Chemical Week;3/27/1996, Vol. 158 Issue 12, p20 

    Reports that DuPont's specialty chemicals unit is studying opportunities for its basic chemicals operations in Asia. Consideration of wholly owned or joint venture manufacturing and licensing; Sales of specialty chemicals unit in Asia and the Pacific.

  • DuPont adipic plant running, helping nylon. Brand, Tony // Chemical Market Reporter;12/15/97, Vol. 252 Issue 24, p1 

    Reports on E.I. du Pont de Nemours & Co.'s startup of its worldscale adipic acid plant in Singapore. Alleviation of feedstock pressure on nylon 6/6 producers; Sampling of products from the plant by customers in Asia and Japan; Shortage of caprolactam worldwide.

  • DuPont To Restructure Dibasic Esters.  // Chemical Market Reporter;10/05/98, Vol. 254 Issue 14, p8 

    Reports on the plan of E.I. du Pont de Nemours & Co. to refocus the strategy of its dibasic esters business. Using technical and research teams to support the development of formulations; Increasing global marketing; Maintaining reliable supply from five global plants.

  • DuPont opened its new Innovation Center In Turkey.  // Colourage;May2013, Vol. 60 Issue 5, p97 

    The article reports that the chemical firm DuPont has opened its Innovation Center of science in Turkey on 11 April, 2013.

  • DuPont proposes a $100-million adiponitrile plant in China. Wood, Andrew // Chemical Week;8/25/1993, Vol. 153 Issue 7, p22 

    Reports on DuPont's proposal to build an intermediate adiponitrile (ADN) plant that uses butadiene-based technology in China. Expected cost; Feasibility study to determine plant location and capacity; Adipic acid plant in Singapore; Unconfirmed partnership with Asahi Chemical; Growth of ADN...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics